What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Alzheimer's disease
Douglas Galasko mainly investigates Alzheimer's disease, Dementia, Disease, Pathology and Degenerative disease.
His Alzheimer's disease research is included under the broader classification of Internal medicine.
His Dementia research includes elements of Psychiatry and Gerontology.
His Psychiatry research integrates issues from Primary progressive aphasia, Donepezil, Risk factor and Intensive care medicine.
The Disease study combines topics in areas such as Developmental psychology, Severity of illness, Neuroscience and Locus.
His Degenerative disease study integrates concerns from other disciplines, such as Differential diagnosis, Apolipoprotein E and Frontotemporal dementia.
His most cited work include:
- Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium (3883 citations)
- Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop (3554 citations)
- Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria (3224 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Disease, Dementia, Alzheimer's disease, Internal medicine and Pathology.
His work carried out in the field of Disease brings together such families of science as Neuroscience, Pediatrics and Intensive care medicine.
His Dementia study combines topics in areas such as Psychiatry, Cognition and Neuropsychology.
His research integrates issues of Audiology, Clinical psychology and Cognitive decline in his study of Cognition.
Douglas Galasko focuses mostly in the field of Alzheimer's disease, narrowing it down to matters related to Gerontology and, in some cases, Activities of daily living.
Douglas Galasko has included themes like Endocrinology and Oncology in his Internal medicine study.
He most often published in these fields:
- Disease (37.07%)
- Dementia (37.83%)
- Alzheimer's disease (35.93%)
What were the highlights of his more recent work (between 2018-2021)?
- Disease (37.07%)
- Internal medicine (32.89%)
- Cognition (18.82%)
In recent papers he was focusing on the following fields of study:
Douglas Galasko spends much of his time researching Disease, Internal medicine, Cognition, Dementia and Biomarker.
His study looks at the intersection of Disease and topics like microRNA with RNA.
His biological study spans a wide range of topics, including Gastroenterology, Endocrinology and Oncology.
His Cognition study also includes fields such as
- Cognitive decline which is related to area like Neurodegeneration and Neuroscience,
- Amyloid that connect with fields like Activities of daily living and Gerontology.
Douglas Galasko is studying Lewy body, which is a component of Dementia.
His research in Dementia with Lewy bodies intersects with topics in Genetics, Genetic variability and Medical genetics.
Between 2018 and 2021, his most popular works were:
- Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease (108 citations)
- Research criteria for the diagnosis of prodromal dementia with Lewy bodies (61 citations)
- Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease (50 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
The scientist’s investigation covers issues in Disease, Cognitive impairment, Dementia, Internal medicine and Neuroimaging.
His study on Apolipoprotein E and Dementia with Lewy bodies is often connected to Induced pluripotent stem cell and Ectoderm as part of broader study in Disease.
Douglas Galasko interconnects Cognition and Neuropsychology in the investigation of issues within Dementia.
His Cognition study deals with Audiology intersecting with Boston Naming Test and Alzheimer's disease.
Particularly relevant to Cerebrospinal fluid is his body of work in Internal medicine.
His studies in Neuroimaging integrate themes in fields like Alzheimer's Disease Neuroimaging Initiative and Reversion.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
